Kaleb E. Rumicho

Associate

Minneapolis + 1.612.217.8865

Connect:

Share

Kaleb Rumicho represents public and private companies on transactional and corporate law matters, including domestic and cross-border mergers & acquisitions, corporate restructurings, and other strategic transactions.

Kaleb has advised clients on a variety of transactions, including Meridian Bioscience's $1.53 billion sale to SD Biosensor and SJL Partners, Eastman Chemical's $1 billion sale of its adhesive resins business to Synthomer, and Sonepar's acquisitions of Echo Electric. Kaleb's transactional experience also includes work with Cargill, Polaris, Cardinal Health, Artis Biosolutions, and Accurate Background, among others.

In addition to his transactional practice, Kaleb is committed to pro bono work, regularly assisting nonprofit organizations with corporate governance and transactional matters. He is actively involved in the Firm's Border Project and serves on the board of trustees of Wallin Education Partners as well as the board of directors of Twin Cities Diversity in Practice (TCDIP).

Prior to joining Jones Day, Kaleb served in government and began his legal career as an associate at an international law firm based in Minneapolis. There, he represented clients ranging from emerging companies to established corporations and private equity firms in all aspects of commercial and debt finance transactions, mergers & acquisitions, and general corporate matters.

Kaleb also spent five years working in education and politics before attending law school.

Experience

  • Artis BioSolutions acquires Landmark BioJones Day advised Artis BioSolutions, a newly launched company dedicated to streamlining the discovery, process development, and manufacturing of genetic medicines, in its acquisition of Landmark Bio, allowing expansion of manufacturing and commercialization of advanced therapies.
  • Molex acquires AirBornJones Day is advising Molex, a leading global connectivity and electronics solutions provider, in the acquisition of AirBorn, Inc., a company specializing in the design and manufacturing of rugged connectors and electronic components for global Original Equipment Manufacturers (OEMs) serving the aerospace and defense, commercial air, space exploration, medical, and industrial markets.
  • Sonepar acquires Echo Electric SupplyJones Day advised Sonepar in the acquisition of Echo Electric Supply, a wholesale electrical distributor ranked in the top 30 of Electrical Wholesaling’s 2024 North America distributors list and headquartered in Council Bluffs, Iowa.
  • Accurate Background acquires Orange Tree Employment Screening LLCJones Day advised Accurate Background, the largest privately held and minority-owned global provider of compliant background checks, drug and health screening, and workforce monitoring solutions, in its acquisition of Orange Tree Employment Screening, a technology-driven background screening provider.
  • Cardinal Health merges its Outcomes™ business into Transaction Data SystemsJones Day advised Cardinal Health, Inc. (NYSE: CAH) in connection with the combination of its Outcomes™ business to Transaction Data Systems, a portfolio company of BlackRock Long Term Private Capital and GTCR, in exchange for a minority stake in the combined entity.
  • Meridian Bioscience agrees to be acquired by SD Biosensor and SJL Partners in $1.53 billion all-cash transactionJones Day advised Meridian Bioscience, Inc. in its $1.53 billion all-cash acquisition by SD Biosensor and SJL Partners.
  • Cargill acquires Owensboro GrainJones Day advised Cargill, Incorporated in the acquisition of Owensboro Grain Company.
  • Infinite Computer Solutions acquires SIS unit, Costa Rica operations of FiservJones Day advised Infinite Computer Solutions, Inc. in the acquisition of the systems integration ervices unit and Costa Rica operations of Fiserv.
  • Polaris sells Transamerican Auto Parts business to Wheel ProsJones Day is representing Polaris Inc. in the sale of its Transamerican Auto Parts business to Wheel Pros, a designer, manufacturer, and distributor of proprietary branded aftermarket vehicle enhancements for light trucks, SUVs, passenger cars, and ATVs/UTVs, backed by Clearlake Capital Group, L.P.
  • Eastman sells adhesives resins business product lines for $1 billionJones Day advised Eastman Chemical Company in the $1 billion sale of its adhesives resins assets and business to Synthomer plc.
  • Calyxt completes $10.9 million placement of Common Stock and WarrantsJones Day represented Calyxt, Inc. in connection with the placement to an institutional investor in an underwritten offering of 3,880,000 shares of its Common Stock, pre-funded warrants to purchase up to 3,880,000 shares of its Common Stock, and Common Warrants to purchase up to 7,760,000 shares of its Common Stock.
  • Morgan Stanley Capital Partners acquires Omega PackagingJones Day advised Morgan Stanley Capital Partners in the acquisition and financing by portfolio company Comar of Omega Packaging, a manufacturer of injection and blow molded products serving the pharmaceutical, nutraceutical, sports nutrition, and skin care markets.
  • Morgan Stanley Capital Partners provides term loans to North Haven Goldfinch Topco, LLCJones Day represented Morgan Stanley Capital Partners, as sponsor, in connection with term loans provided to North Haven Goldfinch Topco, LLC related to its indirect subsidiary's acquisition of Omega Packaging.
  • BioUrja Group acquires ADM's ethanol plant in Peoria, IllinoisJones Day advised BioUrja Group in the acquisition of ADM's ethanol production complex in Peoria, Illinois.
  • Calyxt establishes $50 million at-the-market equity programJones Day represented Calyxt, Inc., a plant-based technology company, in connection with the establishment of an at-the-market offering program for up to $50 million of its Common Stock.
    • View All

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.